Product Name

  • Name

    Clarithromycin

  • EINECS 1806241-263-5
  • CAS No. 81103-11-9
  • Article Data13
  • CAS DataBase
  • Density 1.184 g/cm3
  • Solubility 99.48mg/L(20 oC)
  • Melting Point 217-220 °C
  • Formula C38H69NO13
  • Boiling Point 805.478 °C at 760 mmHg
  • Molecular Weight 747.965
  • Flash Point 440.937 °C
  • Transport Information
  • Appearance Colourless crystalline needles
  • Safety 26-36
  • Risk Codes 22-36/37/38
  • Molecular Structure Molecular Structure of 81103-11-9 (Clarithromycin)
  • Hazard Symbols HarmfulXn, IrritantXi
  • Synonyms Adel;Mabicrol;TE 031;Klaricid;Biaxin (TN);(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione;Clarithromycine [INN-French];Clacine;Trovafloxacin & Clarithromycin;6-o-Methoxyerythromycin;(3R,4S,6R,7R,9R,11R,12R,13R,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione;Abbott-56268;Clarith;Klacid;Claritromicina [INN-Spanish];Klaciped;6-O-Methylerythromycin A;Kofron;Heliclar;Klarin;TE-031;TE031;Maclar;Klaricid Pediatric;Biaxin;(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione;Helas;Veclam;Klarid;Clathromycin;Zeclar;Clarithromycinum [INN-Latin];Claribid;Klax;Mavid;
  • PSA 182.91000
  • LogP 2.43970

Synthetic route

6-O-methylerythromycin A N-oxide
118074-07-0

6-O-methylerythromycin A N-oxide

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Stage #1: 6-O-methylerythromycin A N-oxide With tin(ll) chloride In isopropyl alcohol at 30 - 40℃; for 2h;
Stage #2: With sodium hydrogencarbonate In water; isopropyl alcohol
96%
With bis(tri-n-butyltin) In tetrahydrofuran for 24h; Heating / reflux;95%
With hydrogen; W4 Raney-nickel In ethanol at 40 - 50℃; for 3h;92%
With potassium hydroxide; nickel-aluminum alloy In methanol; water at 35 - 40℃; for 3.5h;92%
Stage #1: 6-O-methylerythromycin A N-oxide With tin(ll) chloride In dichloromethane at 20℃; for 1.5h;
Stage #2: With sodium carbonate In dichloromethane; water
32%
clarythromycin 9-O-(2-pyrimidyl)oxime
930287-49-3

clarythromycin 9-O-(2-pyrimidyl)oxime

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
With sodium hydrogensulfite In ethanol; water at 80℃; for 6h;95%
formaldehyd
50-00-0

formaldehyd

6-O-methylerythromycin A N-oxide
118074-07-0

6-O-methylerythromycin A N-oxide

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Stage #1: 6-O-methylerythromycin A N-oxide With sodium hydrogensulfite In ethanol; water at 20℃; for 1h;
Stage #2: With sodium carbonate In ethanol; water
Stage #3: formaldehyd With formic acid; sodium carbonate more than 3 stages;
92%
Stage #1: 6-O-methylerythromycin A N-oxide With sodium hydrogensulfite In ethanol; water at 20℃; for 1h;
Stage #2: With sodium carbonate In ethanol; water
Stage #3: formaldehyd With formic acid; ammonia more than 3 stages;
30%
clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
With sodium disulfide In ethanol Heating;68%
9-deoxo-9-imino-6-O-methylerythromycin A
130034-54-7

9-deoxo-9-imino-6-O-methylerythromycin A

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
With water In methanol at 23℃; pH 12.4 or pH 7;
With hydrogenchloride; water In ethanol pH=5 - 6;
2',4''-[O-bis(trimethylsilyl)]clarithromycin 9-[O-(dimethylthexylsilyl)oxime]

2',4''-[O-bis(trimethylsilyl)]clarithromycin 9-[O-(dimethylthexylsilyl)oxime]

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
With sodium metabisulfite; formic acid In ethanol for 0.5h; Hydrolysis; Heating;4.32 g
6-(4-dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydro-pyran-2-yloxy)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione 10-(O-pyrimidin-2-yl-oxime)
930287-46-0

6-(4-dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydro-pyran-2-yloxy)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione 10-(O-pyrimidin-2-yl-oxime)

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 90 percent / trimethylsilyl-imidazole / CH2Cl2 / 2 h / 0 °C
2: 83 percent / KOH / dimethylsulfoxide
3: 97 percent / HCO2H / ethanol; H2O
4: 95 percent / sodium hydrogen sulfite / ethanol; H2O / 6 h / 80 °C
View Scheme
C48H88N4O13Si2
930287-48-2

C48H88N4O13Si2

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 97 percent / HCO2H / ethanol; H2O
2: 95 percent / sodium hydrogen sulfite / ethanol; H2O / 6 h / 80 °C
View Scheme
2',4''-O-bistrimethylsilyl erythromycin A 9-O-(2-pyrimydyl)oxime
930287-47-1

2',4''-O-bistrimethylsilyl erythromycin A 9-O-(2-pyrimydyl)oxime

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 83 percent / KOH / dimethylsulfoxide
2: 97 percent / HCO2H / ethanol; H2O
3: 95 percent / sodium hydrogen sulfite / ethanol; H2O / 6 h / 80 °C
View Scheme
erythromycin A (9E)-oxime hydrochloride

erythromycin A (9E)-oxime hydrochloride

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 93 percent / t-BuOK / 2 h / 80 °C
2: 90 percent / trimethylsilyl-imidazole / CH2Cl2 / 2 h / 0 °C
3: 83 percent / KOH / dimethylsulfoxide
4: 97 percent / HCO2H / ethanol; H2O
5: 95 percent / sodium hydrogen sulfite / ethanol; H2O / 6 h / 80 °C
View Scheme
6-methoxyerythromycin A 9-oxime
127253-06-9

6-methoxyerythromycin A 9-oxime

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 25 percent / Bu3P / tetrahydrofuran; dioxane
2: H2O; HCl / ethanol / pH 5 - 6
View Scheme
Multi-step reaction with 2 steps
1.1: PySeSePy; Me3P / tetrahydrofuran / 0.17 h / 0 °C
1.2: 80 percent / H2O / pH 10
2.1: H2O; HCl / ethanol / pH 5 - 6
View Scheme
erythromycin A 9-(E)-oxime
111321-02-9

erythromycin A 9-(E)-oxime

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 90 percent / Et3N / dimethylformamide / 1 h / 20 °C
2: 95.1 percent / 1-trimethylsilylimidazole / ethyl acetate / 1 h / 20 °C
3: 8.82 g / NaH / tetrahydrofuran; dimethylsulfoxide / 1 h / 0 - 5 °C
4: 4.32 g / formic acid; Na2S2O5 / ethanol / 0.5 h / Heating
View Scheme
erythromycin A 9-[O-(dimethylthexylsilyl)oxime]

erythromycin A 9-[O-(dimethylthexylsilyl)oxime]

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 95.1 percent / 1-trimethylsilylimidazole / ethyl acetate / 1 h / 20 °C
2: 8.82 g / NaH / tetrahydrofuran; dimethylsulfoxide / 1 h / 0 - 5 °C
3: 4.32 g / formic acid; Na2S2O5 / ethanol / 0.5 h / Heating
View Scheme
2',4''-[O-bis(trimethylsilyl)]erythromycin A 9-[O-(dimethylthexylsilyl)oxime]

2',4''-[O-bis(trimethylsilyl)]erythromycin A 9-[O-(dimethylthexylsilyl)oxime]

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 8.82 g / NaH / tetrahydrofuran; dimethylsulfoxide / 1 h / 0 - 5 °C
2: 4.32 g / formic acid; Na2S2O5 / ethanol / 0.5 h / Heating
View Scheme
6-O-methyl-N-demethylerythromycin A 9-oxime
101666-67-5, 127182-43-8

6-O-methyl-N-demethylerythromycin A 9-oxime

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: HCOOH / ethanol / Heating
2: 68 percent / Na2S2 / aq. ethanol / Heating
View Scheme
Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: H2 / catalytic hydrogenation
2: HCOOH / ethanol / Heating
3: 68 percent / Na2S2 / aq. ethanol / Heating
View Scheme
Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 76 percent / KOH / dimethylsulfoxide; tetrahydrofuran
2: H2 / catalytic hydrogenation
3: HCOOH / ethanol / Heating
4: 68 percent / Na2S2 / aq. ethanol / Heating
View Scheme
Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: CHCl3 / isomerization
2: 82 percent / NaH / dimethylformamide
3: 76 percent / KOH / dimethylsulfoxide; tetrahydrofuran
4: H2 / catalytic hydrogenation
5: HCOOH / ethanol / Heating
6: 68 percent / Na2S2 / aq. ethanol / Heating
View Scheme
Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 82 percent / NaH / dimethylformamide
2: 76 percent / KOH / dimethylsulfoxide; tetrahydrofuran
3: H2 / catalytic hydrogenation
4: HCOOH / ethanol / Heating
5: 68 percent / Na2S2 / aq. ethanol / Heating
View Scheme
2'-O,3'-N-bis(benzyloxycarbonyl)-N-demethylerythromycin A
81103-09-5

2'-O,3'-N-bis(benzyloxycarbonyl)-N-demethylerythromycin A

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: NH2OH*HCl, AcONa / methanol
2: CHCl3 / isomerization
3: 82 percent / NaH / dimethylformamide
4: 76 percent / KOH / dimethylsulfoxide; tetrahydrofuran
5: H2 / catalytic hydrogenation
6: HCOOH / ethanol / Heating
7: 68 percent / Na2S2 / aq. ethanol / Heating
View Scheme
Multi-step reaction with 6 steps
1: 75 percent / NH2OH*HCl, AcONa / methanol
2: 82 percent / NaH / dimethylformamide
3: 76 percent / KOH / dimethylsulfoxide; tetrahydrofuran
4: H2 / catalytic hydrogenation
5: HCOOH / ethanol / Heating
6: 68 percent / Na2S2 / aq. ethanol / Heating
View Scheme
3-O-descladinosyl-9-oxime clarithromycin
103450-87-9

3-O-descladinosyl-9-oxime clarithromycin

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 0.78 g / ammonium acetate, 15percent aq. titanium(III) chloride / methanol / 6 h
2: H2O / methanol / 23 °C / pH 12.4 or pH 7
View Scheme
(9-E)-deoxo-9-hydroximinoerythromycin A
13127-18-9

(9-E)-deoxo-9-hydroximinoerythromycin A

methyl iodide
74-88-4

methyl iodide

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Stage #1: (9-E)-deoxo-9-hydroximinoerythromycin A; methyl iodide With 2-Methoxypropene; Pyridine hydrobromide; potassium hexamethylsilazane In dichloromethane
Stage #2: With formic acid; sodium hydrogensulfite In ethanol; dichloromethane at 82 - 84℃;
2',4-O-bis(trimethylsilyl)-6-O-methylerythromycin A 9-(E)-O-(1-isopropoxycyclohexyl)-oxime
791845-56-2

2',4-O-bis(trimethylsilyl)-6-O-methylerythromycin A 9-(E)-O-(1-isopropoxycyclohexyl)-oxime

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Stage #1: 2',4-O-bis(trimethylsilyl)-6-O-methylerythromycin A 9-(E)-O-(1-isopropoxycyclohexyl)-oxime With formic acid In ethanol; water at 40 - 45℃; for 3h; pH=2.5 - 3.5;
Stage #2: With sodium hydrogensulfite In ethanol; water for 1h; Product distribution / selectivity; Heating / reflux;
clarithromycin acetate
643726-97-0

clarithromycin acetate

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
at 120℃; for 4h; under vacuum;
clarithromycin trifluoroacetate

clarithromycin trifluoroacetate

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 40℃; for 1h; pH=9 - 11; Product distribution / selectivity;
clarithromycin para-toluene sulphonate

clarithromycin para-toluene sulphonate

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 40℃; for 1h; pH=9 - 11; Product distribution / selectivity;
clarithromycin oxalate

clarithromycin oxalate

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 40℃; for 1h; pH=9 - 11; Product distribution / selectivity;
2',4"-O-bis (trimethylsilyl)-6-O-methylerythromycin A 9-[O-(1-methoxy-1-methylethyl)oxime]
119699-81-9

2',4"-O-bis (trimethylsilyl)-6-O-methylerythromycin A 9-[O-(1-methoxy-1-methylethyl)oxime]

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Stage #1: 2',4"-O-bis (trimethylsilyl)-6-O-methylerythromycin A 9-[O-(1-methoxy-1-methylethyl)oxime] With formic acid; sodium hydrogensulfite In denatured spirit for 2h; Heating / reflux;
Stage #2: With sodium hydroxide In denatured spirit; water at 20℃; pH=10.5; Product distribution / selectivity;
6-O-methyl-2',4-bis(trimethylsilyl)-erythromycin A 9-O-(2-methoxyprop-2-yl)oxime
119685-39-1

6-O-methyl-2',4-bis(trimethylsilyl)-erythromycin A 9-O-(2-methoxyprop-2-yl)oxime

clarithromycin
81103-11-9

clarithromycin

Conditions
ConditionsYield
Stage #1: 6-O-methyl-2',4-bis(trimethylsilyl)-erythromycin A 9-O-(2-methoxyprop-2-yl)oxime With sodium metabisulfite; formic acid; water In ethanol at 25 - 63℃; for 10h; pH=3.8 - 4.1;
Stage #2: With sodium hydroxide In ethanol; water at 30 - 35℃; for 0.5h; pH=10.5 - 11.0; Product distribution / selectivity;
clarithromycin
81103-11-9

clarithromycin

acetic anhydride
108-24-7

acetic anhydride

2',4''-di-O-acetyl-6-O-methylerythromycin A
152235-55-7

2',4''-di-O-acetyl-6-O-methylerythromycin A

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 20℃;100%
With dmap; triethylamine In dichloromethane at 20℃; for 17h;99%
With dmap In dichloromethane at 20℃; for 18h; Inert atmosphere;99%
clarithromycin
81103-11-9

clarithromycin

acetic anhydride
108-24-7

acetic anhydride

2'-O-acetyl-6-O-methylerythromycin A
103461-66-1

2'-O-acetyl-6-O-methylerythromycin A

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 48h;99%
With triethylamine at 20℃;95%
With triethylamine In dichloromethane at 20℃; for 12h;95%
clarithromycin
81103-11-9

clarithromycin

3'-N,N-didemethyl-6-O-methylerythromycin A
118058-75-6

3'-N,N-didemethyl-6-O-methylerythromycin A

Conditions
ConditionsYield
With iodine; sodium acetate In methanol; water at 20℃; for 0.25h; UV-irradiation;99%
clarithromycin
81103-11-9

clarithromycin

benzoic acid anhydride
93-97-0

benzoic acid anhydride

clarithromycin dibenzoate
484670-64-6

clarithromycin dibenzoate

Conditions
ConditionsYield
With 2-(dimethylamino)pyrimidine; triethylamine In N,N-dimethyl-formamide at 45℃; for 4h;98%
With dmap; triethylamine In ethyl acetate at 70℃; for 16h;97%
With dmap; triethylamine In dichloromethane55%
clarithromycin
81103-11-9

clarithromycin

3-O-descladinosylclarithromycin
118058-74-5

3-O-descladinosylclarithromycin

Conditions
ConditionsYield
With hydrogenchloride In water at 20℃; for 0.5h;96%
Stage #1: clarithromycin With hydrogenchloride In methanol; water at 20℃;
Stage #2: With sodium hydroxide In methanol; water pH=10 - 11;
96%
With hydrogenchloride In water at 20℃; for 3h;96%
clarithromycin
81103-11-9

clarithromycin

6-O-methyl-9-hydrazono erythromycin A

6-O-methyl-9-hydrazono erythromycin A

Conditions
ConditionsYield
With hydrazinium monoacetate In methanol for 46h; Reflux;95.1%
With hydrazinium monoacetate In methanol for 46h; Reflux;70%
clarithromycin
81103-11-9

clarithromycin

propargyl bromide
106-96-7

propargyl bromide

C41H72NO13(1+)*Br(1-)

C41H72NO13(1+)*Br(1-)

Conditions
ConditionsYield
In acetonitrile at 20℃; Inert atmosphere;94%
clarithromycin
81103-11-9

clarithromycin

C42H76NO13(1+)*Br(1-)

C42H76NO13(1+)*Br(1-)

Conditions
ConditionsYield
In acetonitrile at 20℃; Inert atmosphere;94%
clarithromycin
81103-11-9

clarithromycin

3-phenylprop-2-en-1-yl bromide
4392-24-9

3-phenylprop-2-en-1-yl bromide

C47H78NO13(1+)*Br(1-)

C47H78NO13(1+)*Br(1-)

Conditions
ConditionsYield
In acetonitrile at 20℃; Inert atmosphere;93%
clarithromycin
81103-11-9

clarithromycin

N-desmethylclarithromycin
101666-68-6

N-desmethylclarithromycin

Conditions
ConditionsYield
Stage #1: clarithromycin With iodine; sodium acetate In methanol; water at 55 - 60℃; for 3h;
Stage #2: With ammonia In methanol; chloroform; water
92%
Stage #1: clarithromycin With iodine; sodium acetate In methanol; water at 55 - 60℃; for 3h;
Stage #2: With ammonia In methanol; chloroform; water
92%
With iodine; sodium acetate In methanol; water at 55 - 60℃; for 3h;92%
clarithromycin
81103-11-9

clarithromycin

6-O-methylerythromycin A N-oxide
118074-07-0

6-O-methylerythromycin A N-oxide

Conditions
ConditionsYield
With dihydrogen peroxide In methanol; water at 20℃; for 15h;92%
adipic anhydride
2035-75-8

adipic anhydride

clarithromycin
81103-11-9

clarithromycin

C44H77NO16

C44H77NO16

Conditions
ConditionsYield
With dmap In chloroform at 110℃; for 8h; Temperature;91%
clarithromycin
81103-11-9

clarithromycin

prenyl bromide
870-63-3

prenyl bromide

C43H78NO13(1+)*Br(1-)

C43H78NO13(1+)*Br(1-)

Conditions
ConditionsYield
In acetonitrile at 20℃; Inert atmosphere;91%
clarithromycin
81103-11-9

clarithromycin

3-O-descladinosyl-9-oxime clarithromycin
103450-87-9

3-O-descladinosyl-9-oxime clarithromycin

Conditions
ConditionsYield
Stage #1: clarithromycin With hydroxylamine hydrochloride; sodium acetate In methanol at 75℃; for 12h;
Stage #2: With hydrogenchloride In methanol; water at 75℃; for 5h;
90%
With hydroxylamine hydrochloride; triethylamine In methanol for 24h; Heating;2.2 g
Stage #1: clarithromycin With hydroxylamine hydrochloride; sodium carbonate In methanol at 20 - 65℃; for 12 - 24h;
Stage #2: With sodium hydroxide In methanol; dichloromethane; water pH=9 - 12;
clarithromycin
81103-11-9

clarithromycin

6-methoxyerythromycin A 9-oxime
127253-06-9

6-methoxyerythromycin A 9-oxime

Conditions
ConditionsYield
With hydroxylamine hydrochloride; sodium acetate at 80℃;90%
With hydroxylamine; acetic acid In water; isopropyl alcohol at 40℃; for 120h; Inert atmosphere;64%
3-Bromomethylthiophene
34846-44-1

3-Bromomethylthiophene

clarithromycin
81103-11-9

clarithromycin

C43H74NO13S(1+)*Br(1-)

C43H74NO13S(1+)*Br(1-)

Conditions
ConditionsYield
In acetonitrile at 20℃; Inert atmosphere;89%
clarithromycin
81103-11-9

clarithromycin

allyl bromide
106-95-6

allyl bromide

Br(1-)*C41H74NO13(1+)

Br(1-)*C41H74NO13(1+)

Conditions
ConditionsYield
In acetonitrile at 20℃; Inert atmosphere;88%
In N,N-dimethyl-formamide at 20℃; for 1.25h;
phosgene
75-44-5

phosgene

clarithromycin
81103-11-9

clarithromycin

allyl alcohol
107-18-6

allyl alcohol

4''-O-(allyloxycarbonyl)-N-demethylclarithromycin 2',3'-carbamate-11,12-carbonate
898833-50-6

4''-O-(allyloxycarbonyl)-N-demethylclarithromycin 2',3'-carbamate-11,12-carbonate

Conditions
ConditionsYield
Stage #1: phosgene; clarithromycin With pyridine In dichloromethane; toluene at 20℃; for 5h;
Stage #2: allyl alcohol In dichloromethane; toluene at 20℃; for 0.5h; Further stages.;
87%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

clarithromycin
81103-11-9

clarithromycin

6-O-Methyl-2',4''-O-bis(trimethylsilyl)erythromycin A
130073-49-3

6-O-Methyl-2',4''-O-bis(trimethylsilyl)erythromycin A

Conditions
ConditionsYield
With 1-(Trimethylsilyl)imidazole In dichloromethane for 0.5h; Ambient temperature;80%
triethylsilyl chloride
994-30-9

triethylsilyl chloride

clarithromycin
81103-11-9

clarithromycin

2',4''-di-TES-6-O-methyl-erythromycin A
1009561-37-8

2',4''-di-TES-6-O-methyl-erythromycin A

Conditions
ConditionsYield
With dmap; triethylamine In acetonitrile at 0 - 30℃; Inert atmosphere;80%
clarithromycin
81103-11-9

clarithromycin

3-hydroxy-6-O-methyl-10,11-anhydroerythromycin A
208456-82-0

3-hydroxy-6-O-methyl-10,11-anhydroerythromycin A

Conditions
ConditionsYield
Stage #1: clarithromycin With [1,3]-dioxolan-2-one; triethylamine for 44h; Heating / reflux;
Stage #2: With hydrogenchloride In ethanol; water at 20℃; for 24h;
Stage #3: With potassium hydroxide In ethanol; water pH=10 - 11;
74%
Multi-step reaction with 5 steps
1: hydrogenchloride / water / 2 h / 20 °C
2: dichloromethane / 1 h / 20 °C
3: pyridine / dichloromethane / 9 h / -5 °C
4: potassium tert-butylate; allyl bromide / tetrahydrofuran; dimethyl sulfoxide / 0.5 h / 0 °C
5: methanol / Reflux
View Scheme
clarithromycin
81103-11-9

clarithromycin

C38H62(2)H7NO13

C38H62(2)H7NO13

Conditions
ConditionsYield
With water-d2; lithium carbonate; triisopropylsilanethiol In 1-methyl-pyrrolidin-2-one at 20℃; Irradiation;70%
2-(aminooxy)acetic acid hemihydrochloride

2-(aminooxy)acetic acid hemihydrochloride

clarithromycin
81103-11-9

clarithromycin

9-(O-carboxymethyloxime)clarithromycin

9-(O-carboxymethyloxime)clarithromycin

Conditions
ConditionsYield
In methanol at 30 - 35℃; for 48h;60%
clarithromycin
81103-11-9

clarithromycin

Benzyl isothiocyanate
622-78-6

Benzyl isothiocyanate

2'-O,3'-N-(N-benzylcarbonimidoyl)-3'-N-demethyl-6-O-methylerythromycin A

2'-O,3'-N-(N-benzylcarbonimidoyl)-3'-N-demethyl-6-O-methylerythromycin A

Conditions
ConditionsYield
With iodine; sodium hydrogencarbonate; 2-amino-2-hydroxymethyl-1,3-propanediol In acetonitrile for 2h; Irradiation;56%
clarithromycin
81103-11-9

clarithromycin

9-dihydro-6-O-methylerythromycin A

9-dihydro-6-O-methylerythromycin A

Conditions
ConditionsYield
With sodium tetrahydroborate In tetrahydrofuran; methanol at 0 - 20℃; for 25h; Inert atmosphere;52%
clarithromycin
81103-11-9

clarithromycin

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

2',4''-di-O-methanesulfonyl-6-O-methylerythromycin A
129318-85-0

2',4''-di-O-methanesulfonyl-6-O-methylerythromycin A

Conditions
ConditionsYield
With triethylamine In acetone 1.) 0 to 3 deg C, 30 min, 2.) RT, 2 h;41.7%

Clarithromycin Specification

1. Introduction of Clarithromycin
Clarithromycin is one kind of white or almost white crystalline powder or colourless crystalline needles. The Systematic (IUPAC) name of this chemical is (3R,4S,5S,6R,7R,9R,11S,12R,13S,14S)-6-{[(2S,3R,4S,6R) -4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy} -14-ethyl-12,13-dihydroxy-4-{[(2R,4S,5S,6S)-5-hydroxy -4-methoxy-4,6-dimethyloxan-2-yl]oxy}-7 -methoxy-3,5,7,9,11,13-hexamethyl -1-oxacyclotetradecane-2,10-dione. The Classification Code of it is Anti-Bacterial Agents; Anti-Infective Agents; Antibacterial; Drug / Therapeutic Agent; Enzyme Inhibitors; Human Data; Protein synthesis inhibitors.

Clarithromycin belongs to Antibiotics;APIs;Antibiotics for Research and Experimental Use;Biochemistry;Macrolides (Antibiotics for Research and Experimental Use);Intermediates & Fine Chemicals;Pharmaceuticals;API's;1694 Pharmaceuticals&Personal Care Products;A - KAntibiotics;Antibacterial;Antibiotics A to;Antibiotics A-FAntibiotics;Chemical Structure Class;MacrolidesEPA;Neats;Spectrum of Activity. Besides, it should stored in -20°C Freezer.

2. Properties of Clarithromycin
Physical properties about Clarithromycin are:

(1)Index of Refraction: 1.526; (2)Molar Refractivity: 194 cm3; (3)Molar Volume: 631.9 cm3; (4)Density: 1.18 g/cm3; (5)Solubility: Insoluble; (6)Flash Point: 440.9 °C; (7)Melting Point: 217-220 °C; (8)Surface Tension: 48.7 dyne/cm; (9)Enthalpy of Vaporization: 133.36 kJ/mol; (10)Vapour Pressure: 5.06E-30 mmHg at 25 °C; (11)Boiling Point of 6-o-Methoxyerythromycin: 805.5 °C at 760 mmHg.

3. Structure Descriptors of Clarithromycin
(1)Canonical SMILES: CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC
(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
(2)Isomeric SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
(3)InChI: InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
(4)InChIKey: AGOYDEPGAOXOCK-KCBOHYOISA-N

4. Toxicity of Clarithromycin

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD oral > 5gm/kg (5000mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BLOOD: HEMORRHAGE
Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 1453, 1988.
mouse LD50 intraperitoneal 850mg/kg (850mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
Chemotherapy Vol. 36(Suppl,
mouse LD50 intravenous 173mg/kg (173mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 22, Pg. 769, 1991.
mouse LD50 oral 1230mg/kg (1230mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 1433, 1988.
mouse LD50 subcutaneous > 5gm/kg (5000mg/kg) SKIN AND APPENDAGES (SKIN): CORROSIVE: AFTER TOPICAL EXPOSURE Chemotherapy Vol. 36(Suppl,
rat LD50 intraperitoneal 669mg/kg (669mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
Chemotherapy Vol. 36(Suppl,
rat LD50 oral 1270mg/kg (1270mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 1433, 1988.
rat LD50 subcutaneous > 5gm/kg (5000mg/kg) SKIN AND APPENDAGES (SKIN): CORROSIVE: AFTER TOPICAL EXPOSURE Chemotherapy Vol. 36(Suppl,
women TDLo oral 30mg/kg/3D-I (30mg/kg) CARDIAC: CHANGE IN RATE

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP
Annals of Emergency Medicine. Vol. 30, Pg. 542, 1997.

5. Physical Properties of Clarithromycin

Physical Property Value Units Temp (deg C) Source
Melting Point 220 dec deg C   EXP
pKa Dissociation Constant 8.99 (none) 25 EXP
log P (octanol-water) 3.16 (none)   EXP
Water Solubility 0.342 mg/L 25 EST
Vapor Pressure 8.60E-27 mm Hg 25 EST
Henry's Law Constant 1.73E-29 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 4.78E-10 cm3/molecule-sec 25 EST

6. Safety information of Clarithromycin
A poison by intraperitoneal and intravenous routes. Moderately toxic by ingestion. Human systemic effects. When heated to decomposition it emits toxic vapors of NOx.
Hazard Codes: Xn,Xi
Risk Statements: 22-36/37/38
R22:Harmful if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing.
RTECS: KF4997000

The first aid is as following. Such as: When on the skin: first, should flush skin with plenty of water immediately for at least 15 minutes while removing contaminated clothing. Secondly, get medical aid. Or in the eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Then get medical aid soon. While, it's inhaled: Remove from exposure and move to fresh air immediately. Give artificial respiration while not breathing. When breathing is difficult, give oxygen. And as soon as to get medical aid. Then you have the ingesting of the product : Wash mouth out with water, and get medical aid immediately. In addition, it should be stored only in original container, or keep its container tightly closed.

7. Uses of Clarithromycin
The usage of Clarithromycin (CAS NO.81103-11-9) is a semi-synthetic macrolide antibiotic, a derivative of erythromycin. And it is a macrolide antibiotic used to treat upper and lower respiratory tract infections, skin and soft tissue infections. Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia, skin and skin structure infections. In addition, it is sometimes used to treat legionellosis, Helicobacter pylori, and lyme disease.

8. Production of Clarithromycin
(1)Use Erythromycin as the raw material and get the methyl off amino by using hydrolysis.
(2)Then get it reaction with Benzyl chloroformate and protect 5-tetrahydropyran ring side-chain hydroxyl and amino.
(3)In the methyl iodide reaction of dimethyl sulfoxide and tetrahydrofuran, carry out six on the methylation of hydroxyl and deprotected by catalytic hydrogenolysis,then reaction with the amino-formaldehyde.
(4)Finally,it is reduced to methyl, named clarithromycin.

The detailed steps are as follows:

Production of Clarithromycin

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View